Search results
-
Clinical Research Study on Pre natal Supplementation
Reducing the Risk of Asthma Using Incromega™ TG3322
-
Striving for Global Manufacturing Excellence
Croda Inc proudly announces that its manufacturing sites in New Castle, Delaware and Mill Hall, Pennsylvania have been awarded the EFfCI’s (The European Federation for Cosmetic Ingredients) GMP (Good Manufacturing Practice) certification.
-
11th Most Sustainable International Company
We are celebrating being ranked the top of the chemicals sector for the sixth year running in Britain’s Most Admired Companies award
-
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.
-
EcoVadis Rates Crodas Environmental Practices as Outstanding
Croda has been awarded EcoVadis Gold Status for the fourth time
-
EcoVadis Gold Status for the Third Year Running
Croda, who create, make and sell innovative, sustainable, high performance speciality chemicals that are relied on by industries and consumers everywhere has this month been awarded EcoVadis Gold Status for the third year running.
-
Sustainability success with EcoVadis rating
24 May 2022: Sustainability success after retaining its position within the top 1% of companies assessed by EcoVadis
-
Croda retains top spot as Britain’s most admired Chemicals Company
19 March 2024: Croda International Plc maintains its top spot as 'Britain’s Most Admired Chemicals Company' for the seventh consecutive year.
-
Contact investor relations
Receive investor relations updates.
-
Croda opens new manufacturing facility in Dahej, India to support growth and sustainable innovation
Croda inaugurates a new greenfield manufacturing facility in Dahej, India, expanding its capacity to deliver high-performance, science-driven solutions to fast-growing Asian markets.
-
Sustainability
Sustainability spans every area of our business and is a crucial way we add value to our customers.
-
Meet the expert: Will Small, Research & Technology Specialist
Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.
-
Australia
The availability of high quality wool grease, the raw material from which lanolin is manufactured, fuelled Croda’s move into Australia in 1968.
-
Our sustainability leadership
Discover how Croda are driving deeper impact to create greater value across fewer targets.
-
Chief Executive's Statement 2025
An overview from Steve Foots, our Chief Executive, outlining the year’s key achievements, business performance, strategic priorities, and future outlook for growth and innovation.
-
Specialist biotechnology capabilities
At Croda, thanks to our expertise across a wide range of biotechnology specialisms, we are developing new, innovative and sustainable ingredients to support our customers in bringing to market exciting often niche products.
-
Shaping the next generation: Industrial Placements at Croda
Join us as we recognise our Industrial Placement students, their success and their views on our placement opportunities.
-
Investor overview
Croda is a successful global company with 105 operations across 39 countries, a focused Life Sciences and Consumer Care company.
-
CrodaTherm helps COVID 19 ICU nurses in the United States
Croda donates cooling vests to Christiana Care Hospital in Newark, Delaware
-
Steve Foots, Group Chief Executive Letter
We are focused on delivery and modernisation, ensuring rigorous cost discipline and driving operational efficiencies to continue our long record of strong performance.
-
Abiotic stress mitigation in onions
Changing climates mean higher temperatures, periods of drought and higher salinity are becoming an increasing problem for farmers.
-
Investor seminar on our Life Sciences sector
7 October 2019: Senior members of our management team provided a comprehensive overview of the Life Sciences sector, with a particular focus on our Health Care business.
-
Driving consistent growth
-
Procurement and sustainable sourcing
Using natural resources brings a responsibility to ensure no associated negative social or environmental impacts, and an opportunity to advocate and contribute to positive change.
-
Croda expands biopharma capabilities through strategic partnership
9 December 2025: Croda International Plc today announces a strategic supply partnership with Amino GmbH (“Amino”), a leading manufacturer of pharmaceutical-grade amino acids
-
Croda acquires Inventiva, encapsulation and delivery system technology
It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.
-
Strengthening Life Sciences with the acquisition of Avanti Polar Lipids
A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.
-
Strategic investment Entekno Materials
A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.
-
Croda joins forces with academic experts to develop sustainable polymers for a clean future
Croda International Plc and the Universities of Nottingham and York have today announced a collaborative partnership to develop novel, sustainable polymers for liquid formulations.
-
Symiro™ biostimulant
As the challenge to feed our growing global population continues, increasing crop growth and yields is becoming an important area of focus to meet the rising demand for food.
-
Croda becomes founding member of sustainability Business Transformation Group
We are proud to be a founding member of the CISL Business Transformation Group.
-
Croda joins the Together for Sustainability initiative
Croda becomes the 30th member of TfS
-
Contract for innovative delivery system for COVID19 vaccine
We have recently entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate.
-
Croda invests in biopharma innovation with expanded Super Refined™ facility in Leek, UK
25 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, continues to invest in the evolving world of biopharmaceutical manufacturing where consistency and purity in ingredients are critical.
-
Record performance driven by accelerated strategic implementation
Croda International results for the six months ended 30 June 2021
-
First quarter 2025 sales update
23 April 2025: Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the first quarter of 2025 (the three months ended 31 March 2025).
-
Croda’s first product launch specifically focusing on the biopesticide market
28 September 2023: Croda has launched the new product Atlox™ BS-50, a delivery system which specifically meets the needs of the growing biopesticide market.
-
C4C Lead via SnapEngage
C4C Lead via SnapEngage
-
Life Sciences
We provide high-quality healthcare solutions, protect crops, and enhance seeds, supporting global health and crop sustainability. Our growing range of technologies ensures we deliver high value to customers worldwide.
-
Consumer Care
Consumer Care combines our businesses closest to consumers, offering innovative, sustainable solutions for home care, beauty, personal care, and fragrance. Our expertise enables us to provide tailored formulations to meet global consumer demands.
-
Pharma seminar
7 October 2022: Investor seminar, empowering biologics delivery in Pharma
-
Fragrances & Flavours investor site visit
12 May 2022: Presentation articulating the compelling growth plan for our F&F business as part of an investor site visit.
-
First quarter 2024 results call
Update on trading from 01 January to 31 March.
-
Transition to a dedicated Consumer Care and Life Sciences company
Croda enters agreement to sell majority of Performance Technologies and Industrial Chemicals businesses; completing its transition into a dedicated Consumer Care and Life Sciences company
-
Full year 2022 results
Powerful operating model and consistent execution delivers record performance.
-
Oil and Gas Portfolio Strengthened by Acquisition
Global speciality chemical manufacturer Croda, announces the acquisition of JD Horizons Limited, a UK based business specialising in ‘Solutions for Flow Assurance’ technology.
-
Croda breaks ground on new manufacturing facility for pharmaceutical excipients
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
-
Croda announces Global Technical Centre in Hyderabad
5 June 2023: Croda is investing in the new 23,680 square-foot facility to manufacture ingredients for drug delivery systems used in novel therapeutic drugs.
-
Continued recognition for environmental efforts in FTSE4Good Index Series
22 August 2022: Acknowledging our strong sustainability focus, we continue to be included in the FTSE4Good Index series.
-
Half year 2023 results
Continued investment and strategic progress despite a challenging environment.